Fundz

Biotech Startup Mekonos Raises Oversubscribed $25 Million Round To Overcome Pharma Industry'S Cell & Gene Therapy Delivery Hurdles

PRIVATENov 09, 2021

Amount Raised

$25 Million

Round Type

Funding Round

San FranciscoOtherCommunity And LifestyleHealth Care

Description

Mekonos, a biotech company building the future of cell therapies on a chip, has raised $25M in an oversubscribed Series A round co-led by Reimagined Ventures, Fiscus Ventures, and PEAK6 Strategic Capital, a division of PEAK6 Investments. New institutional and strategic investors, including Section 32, Sands Capital, TDK Ventures, and the venture arm of Debiopharm, and previous investors, including Novartis Pharma AG (dRx Capital) and Elementum Ventures, also joined in the funding round that will support Mekonos' next stages in product development and commercialization.

Quick answer

Mekonos, Inc. raised $25 Million in a Funding Round round, dated November 9, 2021. Mekonos, Inc. is based in San Francisco, California, United States.

How much did Mekonos, Inc. raise?
Mekonos, Inc. raised $25 Million in a Funding Round round on November 9, 2021.
What does Mekonos, Inc. do?
Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line..
Where is Mekonos, Inc. based and how big is it?
Mekonos, Inc. is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Community And Lifestyle and Health Care around the same time

Companies in the same sectors as Mekonos, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Cresco Labs raised $62M on December 21, 2021.
  • PetPlate, Inc. raised $16M on December 17, 2021.
  • Well raised $70M (Series B) on December 17, 2021.
  • The Valens Company raised $32M (Debt Financing) on December 16, 2021.
  • Day Three Labs Inc raised $4.4M (Seed) on December 16, 2021.
  • Belong Health raised $40M (Series A) on December 15, 2021.

Who to call at Mekonos, Inc., and when

A new round usually means Mekonos, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mekonos, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mekonos, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mekonos, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mekonos, Inc.

Location

44 MONTGOMERY STREET, SUITE 300

San Francisco, California, United States

About

Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mekonos, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mekonos, Inc.'s next move

See what Strategic adds

Mekonos, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.